Pediatrics offers full-service support to biotech and pharmaceutical companies from early phase through phase III clinical development, post-approval authorization, and real-world evidence studies across all therapeutic areas.
Our experience has led to strong working relationships with clinical centers, site networks, key opinion leaders (KOLs), and patient advocacy groups
This means that we have a solid understanding of the specific challenges pediatric trials face and have implemented strategies to mitigate risks such as recruitment and retention, data accuracy, regulatory hurdles, and investigator training. We become your study partner delivering on-time, within budget, and with maximum quality.